Jason Amello
Directeur Financier/CFO chez TSCAN THERAPEUTICS, INC.
Fortune : 217 521 $ au 30/04/2024
Provenance du réseau au premier degré de Jason Amello
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
150
| Subsidiary | Medical Specialties | 150 |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY.
62
| Private Company | Miscellaneous Commercial Services | 62 |
| Public Company | Pharmaceuticals: Major | 35 | |
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 17 | |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA.
17
| Private Company | Hospital/Nursing Management | 17 |
9
| Public Company | Biotechnology | 9 |
| Public Company | Biotechnology | 5 | |
| Public Company | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jason Amello via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor Director/Board Member Corporate Officer/Principal | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman Founder Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Notre Dame | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Indiana University | College/University | Undergraduate Degree Masters Business Admin | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| Florida Institute of Certified Public Accountants | Corporate Officer/Principal Corporate Officer/Principal | ||
| Miami University | College/University | Undergraduate Degree Undergraduate Degree | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Chief Operating Officer | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| State University of New York at Buffalo | College/University | Doctorate Degree Graduate Degree | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Corporate Officer/Principal Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Censa Pharmaceuticals, Inc.
 Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Pharmaceuticals: Major | Founder Founder | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Human Resources Officer | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AVROBIO, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| TME PHARMA N.V. | Biotechnology | Chairman Chairman | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| University of Ottawa | College/University | Undergraduate Degree Doctorate Degree | |
| New York University | College/University | Corporate Officer/Principal Masters Business Admin | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 43 |
| Pays-Bas | 3 |
| Danemark | 3 |
| Allemagne | 3 |
| Suisse | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Finance | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 508 |
| Corporate Officer/Principal | 182 |
| Independent Dir/Board Member | 178 |
| Chairman | 103 |
| Chief Executive Officer | 71 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| Luc Marengère | 31 |
| Joseph deBethizy | 29 |
| Hubert Birner | 27 |
| Timothy Barberich | 26 |
| Steven Gilman | 25 |
| Marc Beer | 25 |
| Ronald Renaud | 24 |
| Maxine Gowen | 23 |
| Michael Heffernan | 23 |
| Robert Hoffman | 22 |
| Katina Dorton | 22 |
| Ralph Victor Whitworth | 21 |
- Bourse
- Insiders
- Jason Amello
- Connexions Sociétés
